Showing results (181-190 of 361) with videos related to
Sort By:
Pageof 37
Cancer Research|October 16, 2003
The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasiaTerukazu Nakamura, Andreas Scorilas, Carsten Stephan, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 22, 2012
Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impactMaroulio Talieri, Marina Devetzi, Andreas Scorilas, et al.Genes, Chromosomes & Cancer|November 29, 2017
miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progressionFoteini D Tsikrika, Margaritis Avgeris, Panagiotis K Levis, et al.Clinical and Experimental Medicine|February 14, 2018
Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patientsChristoforos Haritos, Kleita Michaelidou, Konstantinos Mavridis, et al.Biological Chemistry|November 30, 2006
The role of human tissue kallikreins 7 and 8 in intracranial malignanciesPanagiotis Prezas, Andreas Scorilas, Christina Yfanti, et al.Anticancer Research|August 27, 2011
Evaluation of kallikrein-related peptidase 5 expression and its significance for breast cancer patients: association with kallikrein-related peptidase 7 expressionMaroulio Talieri, Marina Devetzi, Andreas Scorilas, et al.Clinical Chemistry and Laboratory Medicine|February 14, 2019
Uncovering the clinical impact of kallikrein-related peptidase 5 (KLK5) mRNA expression in the colorectal adenoma-carcinoma sequenceGeorgia Papachristopoulou, Apostolos Malachias, Marina Devetzi, et al.Journal of Cancer Research and Clinical Oncology|October 10, 2019
ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progressionMaria-Alexandra Papadimitriou, Margaritis Avgeris, Panagiotis K Levis, et al.Clinical Biochemistry|February 28, 2015
L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinomaEmmanuel I Papadopoulos, Constantina Petraki, Alkiviadis Gregorakis, et al.International Journal of Molecular Sciences|March 6, 2021
Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular BackgroundAristea-Maria Papanota, Paraskevi Karousi, Christos K Kontos, et al.Pageof 37